New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 13, 2014
08:58 EDTANIKAnika announces dismissal of MONOVISC patent infringement suit
Anika Therapeutics announced that Genzyme and Anika filed a joint motion with the U.S. District Court for the District of Massachusetts to lift a stay and dismiss a patent infringement lawsuit concerning MONOVISC. MONOVISC received FDA PMA approval in February. The court granted the parties’ motion and issued an order dismissing the litigation with prejudice on March 10. This final and unappealable order resolves the parties’ dispute and is another important milestone toward commercialization of the product in the U.S.
News For ANIK From The Last 14 Days
Check below for free stories on ANIK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
13:48 EDTANIKAnika Therapeutics weakness creates buying opportunity, at Summer Street
Subscribe for More Information
11:58 EDTANIKAnika Therapeutics management to meet with JMP Securities
Subscribe for More Information
July 30, 2014
16:31 EDTANIKAnika Therapeutics reports Q2 EPS 60c, consensus 57c
Subscribe for More Information
13:05 EDTANIKAnika Therapeutics announces U.S. commercialization partnership with Medline
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use